Investing in Biotechnology Stocks
- List Price: $29.95
- Binding: Hardcover
- Publisher: John Wiley & Sons
- Publish date: 08/01/2001
Description:
Top industry insiders tell investors what they need to know to make informed investment decisions about biotech stocks
After Internet stocks, biotechs are today's most popular stock investments, and most serious investors know that biotech is one market they simply cannot afford to stay out of. But when confronted with a highly technical, rapidly evolving sector, consisting of thousands of R&D companies involved in everything from pharmaceuticals to cloning technology, many investors understandably feel unqualified to decide which stocks to pick. This book arms investors with the background knowledge and up-to-the-minute market information they need to play the biotech markets and win. Leading investment author and journalist Leo Gough provides them with a rare insider's look at the biotech industries based on extensive interviews with industry analysts, CEOs, and leading scientists at top biotech firms, including Merck & Co., Eli Lilly & Co., Amgen Ltd., SmithKline Beecham, Inc., Genzyme Corp., Monsanto, and others.
Leo Gough (Singapore) edits a number of investment newsletters on emerging markets and technology stocks and is the author of thirteen investment books.
Expand description
After Internet stocks, biotechs are today's most popular stock investments, and most serious investors know that biotech is one market they simply cannot afford to stay out of. But when confronted with a highly technical, rapidly evolving sector, consisting of thousands of R&D companies involved in everything from pharmaceuticals to cloning technology, many investors understandably feel unqualified to decide which stocks to pick. This book arms investors with the background knowledge and up-to-the-minute market information they need to play the biotech markets and win. Leading investment author and journalist Leo Gough provides them with a rare insider's look at the biotech industries based on extensive interviews with industry analysts, CEOs, and leading scientists at top biotech firms, including Merck & Co., Eli Lilly & Co., Amgen Ltd., SmithKline Beecham, Inc., Genzyme Corp., Monsanto, and others.
Leo Gough (Singapore) edits a number of investment newsletters on emerging markets and technology stocks and is the author of thirteen investment books.
Please Wait